WallStSmart
QNTM

Quantum BioPharma Ltd.

NASDAQ: QNTM · HEALTHCARE · BIOTECHNOLOGY

$5.73
+1.42% today

Updated 2026-04-30

Market cap
$31.77M
P/E ratio
P/S ratio
91.86x
EPS (TTM)
$-8.20
Dividend yield
52W range
$2 – $38
Volume
0.5M

Quantum BioPharma Ltd. (QNTM) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20152016201720182019202020212022202320242025
Revenue$20630.00$0.00$0.00$0.00$0.00$0.00$0.00
Revenue growth (YoY)-100.0%
Cost of revenue$2.04M$490571.00$555334.00
Gross profit$20630.00$-1.84M$-490571.00$-555334.00
Gross margin100.0%
R&D$7.83M$6.33M$6.91M$3.86M$6.08M$2.81M
SG&A$32800.00$29628.00$2.82M$17.49M$20.49M$18.11M$23.37M$15.98M$13.20M$9.31M$12.01M
Operating income$-2.80M$-22.48M$-30.69M$-33.74M$-27.43M$-23.79M$-16.14M$-15.59M
Operating margin-13586.0%
EBITDA$-32800.00$-29628.00$-2.80M$-16.54M$-31.98M$-24.32M$-29.82M$-22.12M$-15.72M$-14.38M$-15.03M
EBITDA margin-13586.0%
EBIT$-16.67M$-33.93M$-28.22M$-33.87M$-26.65M$-18.23M$-14.87M$-15.59M
Interest expense$155316.00$235581.00$69404.00$48822.00$299.00$47577.00$629469.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-32800.00$-29628.00$-2.80M$-16.67M$-39.13M$-31.80M$-35.29M$-23.61M$-17.90M$-14.20M$-26.63M
Net income growth (YoY)+9.7%-9360.0%-494.9%-134.7%+18.7%-11.0%+33.1%+24.2%+20.7%-87.5%
Profit margin-13586.0%